Gibson Neil W

CIK 00015559184 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001555918

Recent Transactions

50 trades

Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2025-07-14+33,150→ 33,150 total
Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2025-05-28+6,500→ 6,500 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2024-06-21+27,700→ 27,700 total
Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2024-06-13+5,000→ 5,000 total
Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2023-06-14+1,500→ 1,500 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−12,100→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−8,072→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−12,100→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−6,270→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−16,800→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−5,000→ 0 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2023-05-26+40,258→ 40,258 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2022-06-08+40,258→ 40,258 total
Award
Instil Bio, Inc.$TIL
Employee Stock Option (right to buy)
2022-05-20+30,000→ 30,000 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09+12,100→ 12,100 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09+16,800→ 16,800 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2021-06-19+3,434→ 3,434 total
Award
Instil Bio, Inc.$TIL
Stock Option (right to buy)
2021-03-18+52,000→ 52,000 total
Award
Shattuck Labs, Inc.$STTK
Stock Option (Right to Buy)
2020-12-22+1,286→ 1,286 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-12-10+12,100→ 12,100 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-20$7.94/sh−648→ 0 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-19$7.41/sh−3,140→ 648 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-18$6.83/sh−3,120→ 3,788 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-17$6.49/sh−3,009→ 6,908 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-16$6.60/sh−17,723→ 9,917 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2020-03-13$6.52/sh−52,000→ 27,640 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-12-19+5,000→ 5,000 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2019-11-15−217,974→ 79,640 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2019-11-13−196,177→ 297,614 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2019-11-07−212,560→ 493,791 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-04-11+6,270→ 6,270 total
Conversion
TCR2 THERAPEUTICS INC.
Series B Preferred Stock
2019-02-19−4,375,000→ 0 total
Conversion
TCR2 THERAPEUTICS INC.
Common Stock
2019-02-19+706,351→ 706,351 total
Sale
Regulus Therapeutics Inc.
Common Stock
2015-01-28$17.98/sh−71,345→ 8,655 total
Sale
Regulus Therapeutics Inc.
Common Stock
2015-01-28$18.66/sh−8,655→ 0 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2014-12-02+90,378→ 90,378 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-11-28$19.63/sh−1,500→ 80,000 total
Exercise/Conversion
Regulus Therapeutics Inc.
Common Stock
2014-11-28$1.74/sh+2,500→ 82,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-11-28$18.80/sh−1,000→ 81,500 total
Exercise/Conversion
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2014-11-28−2,500→ 111,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-10-29$20.41/sh−200→ 80,000 total
Exercise/Conversion
Regulus Therapeutics Inc.
Common Stock
2014-10-29$1.74/sh+2,500→ 82,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-10-29$18.68/sh−1,100→ 81,400 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-10-29$19.67/sh−1,200→ 80,200 total
Exercise/Conversion
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2014-10-29−2,500→ 114,000 total
Exercise/Conversion
Regulus Therapeutics Inc.
Common Stock
2014-10-22$1.74/sh+3,300→ 83,300 total
Exercise/Conversion
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2014-10-22−3,300→ 116,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-10-22$14.44/sh−3,300→ 80,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2014-10-20+40,000→ 40,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2014-09-12$8.01/sh−2,200→ 80,000 total

Gibson Neil W

Recent Transactions

Companies

Recent Filings

Address